Aditxt’s wholly owned subsidiary, Adivir, Inc. will acquire all issued and outstanding Class A common shares of Appili in the transaction. Appili has developed FDA-approved Likmez (previously ATI-1501 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback